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Commentary on ‘General Anaesthesia is Associated with Adverse Cardiac
Outcome after Endovascular Aneurysm Repair’
A. Chaudhuri*
Bedfordshire Vascular Unit, Bedford Hospital NHS Trust, Kempston Road, Bedford MK42 9DJ, United KingdomMuch is being discussed regarding surgical/hospital volume-
related outcomes following AAA surgery. The other side of the
coin, namely how anaesthesia affects EVAR outcomes (though
hinted at in EUROSTAR), seems to be largely ignored. The point
is, post-EVAR cardiac complications, albeit low, could be even
lower with regional anaesthesia (RA), and that RA for EVAR is
not new.
Despite undertaking other procedures under RA, there are
anaesthetists who will simply put a patient asleep out of sheer
convenience/habit, and a matching body of vascular surgeons who
do not question that decision. The anecdotal practice of epidural
insertion followed by intubation is laughable; the same applies to
GA for percutaneous EVAR. Conversions to OR are rare, so a ‘what if’
argument does not apply.
Our default approach is RA, namely an epidural (applicable even
for procedural extension e.g. IBD deployment), avoiding even
transient/unnecessary blood pressure shifts from a spinal, unless
RA is clearly contraindicated. This has several advantages, such as
patient co-operation with breathing whilst imaging, reducing need
for HDU care (patients can have a cup of tea in recovery and go
straight to the ward), reduced pulmonary complications (clearly
demonstrated in this paper) and early discharge,1 exempliﬁed by
our case of a man in his mid-60s, on home oxygenation and under
consideration for a heart-lung transplant, who underwent
successful EVAR under RA and was discharged in 48 h. GA would
not have been an option.
There are other non-quantiﬁable positives from having patients
awake and involved with the procedure, which may also be linked
to stress response attenuation.
The paper by Bakker et al. clearly indicates that even after
excluding grey outcomes such as asymptomatic troponin rise
(despite increasing recognition of such “chemical MIs”) RA would
seem to be another step in further improving EVAR mortality; it
also perhaps paves the way for more questions, such as who should
be anaesthetising for OR/EVAR? There is a move from the Vascular
Anaesthesia Society of Great Britain & Ireland (VASGBI) in thisDOI of original article: 10.1016/j.ejvs.2012.04.028.
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provide useful information in this context.
However, the paper omits examining pulmonary parameters,
given that hypoxia may have had a bearing on adverse cardiac
outcomes e.g. MIs/arrhythmias. This is particularly given that ‘frail’
patients are not so just because of cardiac disease.2 Multivariate
analysis could have looked at links between obesity and cardio-
pulmonary morbidity. Furthermore, as a retrospective study, with
its inherent ﬂaws, there are opportunities missed in correlating
outcomes with outcome-predicting tools (notwithstanding their
weaknesses) such as V/AAA-POSSUM or CPET pre-operatively.
Furthermore, this results in missed opportunities with intra-
operative non-invasive cardiac output monitoring using the
LiDCO, for instance; reliable peri-operative anaesthetic data on
oxygenation could not be obtained, which could have been ana-
lysed in conjunctionwith the recent American paper1 - prospective
studies need to examine these issues.
If we are to focus on outcomes after EVAR, both surgical and
anaesthetic aspects need to be looked at. On the other hand, do we
need a GALA-style trial? Perhaps not. Still, in this era of cash-
strapped (health) economies, there is another lesson in reducing
the costs of EVAR, especially as this gets centralised, and GALA has
suggested that RA is cheaper.3 However, the real message from the
paper is that (a) both vascular anaesthetists and surgeons need to
keep their options open, and from the results of the paper, look
harder at undertaking EVAR under RA, as these results cannot be
ignored, and (b) most importantly, tailor the anaesthetic option to
suit the patient and provide the best outcome, and I congratulate
the authors in trying to get that very message out.References
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